event tracking

Neurodegenerative Diseases

106 results.

April 20, 2026 Van Andel Institute to recognize Dr. Glenda Halliday with the 2026 Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research

GRAND RAPIDS, Mich. (April 20, 2026) — Van Andel Institute has named internationally recognized scientist Glenda Halliday, Ph.D., as the recipient of its 2026…

April 10, 2026 5 areas to watch in Parkinson’s research

[caption id="attachment_35114" align="alignright" width="327"] Dr. Darren Moore[/caption]

As a scientist who studies Parkinson’s disease, I often say that my job is to put myself out…

February 27, 2026 Can a chronic stomach infection influence Parkinson’s disease risk?

Most cases of Parkinson’s disease cannot be attributed to one distinct cause.

Parkinson’s is a progressive disorder characterized by the loss of specialized nerve…

December 19, 2025 Reflecting on research: 2025 highlights

In 2025, VAI continued to build scientific momentum and drive discoveries that deepen our understanding of human health. With the addition of new faculty and…

December 10, 2025 Van Andel Institute, Cure Parkinson’s renew funding for Parkinson’s clinical trials program

GRAND RAPIDS, Mich. (Dec. 10, 2025) — Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials…

October 29, 2025 Eminent physician-scientist Dr. Jonathan D. Licht to serve as next president and chief scientific officer of Van Andel Institute

Grand Rapids, Mich. (Oct. 29, 2025) — Van Andel Institute, a leading research organization based in Grand Rapids, Michigan, has appointed internationally recognized physician-scientist…

October 21, 2025 Not just a harmless accessory, tau’s ‘fuzzy coat’ contributes to Alzheimer’s progression

Alzheimer’s disease is a neurodegenerative disorder that over time interferes with memory, thinking and the ability to perform day-to-day tasks.

It is the most common…

October 16, 2025 Largest-ever Parkinson’s disease clinical trial opens

LONDON (Oct. 16, 2025) — The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by…